Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of PLX4720 on melanoma-associated fibroblasts co-cultured with melanoma cells

ABSTRACT: The experiment was designed to assess the effect of PLX4720 on the gene expression in human primary melanoma-associated fibroblast co-cultired with 5555 mouse melanoma cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE274333 | GEO | 2024/08/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of PLX4720 on melanoma-associated fibroblasts co-cultured with melanoma cells

Project description:The experiment was designed to assess the effect of PLX4720 on the gene expression in human primary melanoma-associated fibroblast co-cultired with 5555 mouse melanoma cells

2014-11-11 | GSE63160 | GEO

Effect of PLX4720 on melanoma cells co-cultured with melanoma-associated fibroblasts

Project description:The experiment was designed to assess the effect of PLX4720 on the gene expression in 5555 mouse melanona cells co-cultured with human primary melanoma-associated fibroblast

2024-07-29 | GSE270933 | GEO

Effect of PLX4720 on melanoma-associated fibroblasts co-cultured with melanoma cells

Project description:Effect of PLX4720 on melanoma-associated fibroblasts co-cultured with melanoma cells

| PRJNA1145976 | ENA

Effect of PLX4720 on melanoma cells co-cultured with melanoma-associated fibroblasts

Project description:Effect of PLX4720 on melanoma cells co-cultured with melanoma-associated fibroblasts

| PRJNA1129063 | ENA

Identification of direct transcriptional targets of V600EBRAF/MEK in melanoma

Project description:A375P melanoma cells were treated with 1uM of the MEK inhibitor PD184352 or 0.4uM of the V600EBRAF inhibitor PLX4720 for 2hr, 6hr and 24hrs. DMSO treatment for 2hr, 6hr and 24hrs serves as the negative control Triplicate experiments were performed for DMSO, PD184352 and PLX4720 treatment at 3 timepoints - 2, 6, 24hrs.

2010-08-18 | E-GEOD-17089 | biostudies-arrayexpress

Expression data of BRAF inhibitor resistant melanoma cells

Project description:We generated four drug-resistant melanoma cell lines from paired primary/metastatic cell lines using PLX4720 and used for Affymetrix Human Gene 1.0 ST array

2019-01-31 | GSE114443 | GEO

RNA-seq of the human melanoma cell-line A375P treated with the BRAF inhibitor PLX4720 and a DMSO control

Project description:The human melanoma cell line A375P was subjected to PLX4720 treatment for 36 hours.

2019-08-07 | E-MTAB-7453 | biostudies-arrayexpress

Identification of direct transcriptional targets of V600EBRAF/MEK in melanoma

2009-08-19 | GSE17089 | GEO

Transcriptomal analysis of the impact of ASAH1 inhibition on skin metastatic melanoma cells

Project description:To assess the impact of ASAH1 inhibition skin metastatic melanoma, we transfected three different human skin metastatic melanoma cell lines (501Mel, WM3912 and WM8) with a siRNA designed against ASAH1 (50nM) or a siRNA control (50nM) for 48h.

2018-12-03 | GSE115385 | GEO

Modeling melanoma resistance in a genetically engineered mouse model

Project description:Melanoma is the deadliest type of skin cancer and its incidence is steadily increasing. Targeting melanoma cells posseses significant challenges due to primary or acquired therapy resistance in the majority of patients. Here, we describe the generation of an in vivo mouse model mimicking the key steps in melanoma initiation, progression and resistance acquisition. The well-characterized Tyr::CreERT2 BrafV600E Ptenfl/fl mouse model was used to induce melanoma initiation and subsequently therapy resistance to a combination of BRAF (PLX4720) and MEK (PD0325901) inhibitors. Our data reveal that all of the Tyr::CreERT2 BrafV600E Ptenfl/fl mice subjected to PLX4720+PD0325901 treatment ultimately developed resistance to these inhibitors. Introduction of genetic labelling by crossing Tyr::CreERT2 BrafV600E Ptenfl/fl mice with the TdTomato reporter allele allowed us not only to observe brain metastasis, which are rarely seen in this mouse model, but also to isolate metastatic melanoma cells using flow cytometry. The comparison of the expression profile of metastatic cells before and after resistance acquisition revealed a number of pathways significantly altered in resistant cells. Here, we describe and characterize a suitable mouse model to explore the molecular and cellular mechanisms of multiple stages of drug resistance in melanoma development. Finally, this experimental model might provide further understanding of the interplay between the immune system and melanoma cells.

2022-01-01 | GSE155537 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data